AfroCentric Investment Corporation (ACT) Fair Value & Analysis
Healthcare · ZA · Market cap 655M ZAC
Fair value as of: Jul 19, 2026
From 15 valuation models · updated yesterday
Fair value updated Jul 19, 2026, revised from R11.37 to R3.14 (−72.4%) since Jun 26, 2026. Share price −7.0% over the past month.
Price vs Fair Value (12 months)
12‑month range R0.7000 – R1.75 · fair‑value band R2.31 – R3.96 · the R0.8000 price screens below the R3.14 fair value. As of Jul 19, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
AfroCentric Investment Corporation (ACT) currently trades at R0.8000, while our model-based Fair Value estimate is R3.14, implying the stock looks roughly 292.5% undervalued today. We read business quality at 39/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, AfroCentric Investment Corporation generated revenue of 7.5B ZAR at a net margin of -17.1%. Revenue declined 2.6% year over year. It earns a return on equity of -24.7%. Net debt stands at 136M ZAR. Fundamentals as of Jul 19, 2026
Our scenario range runs from R2.31 (bear case) to R3.96 (bull case); at R0.8000, the current price sits below that range. For context, the median of 10 Healthcare peers we cover trades at -20% fair-value upside, at 293%, ACT screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 19, 2026. TTM = trailing twelve months.
About the company
AfroCentric Investment Corporation Limited, an investment holding company, provides healthcare products and services to private and public sectors in South Africa and internationally. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It offers health administration, health risk management, medical scheme administration, marketing and distribution, as well as specialized and technology-based products and services; HIV/AIDS management; DBC equipment and administration services to musculoskeletal treatment centres; and dental management services. The company also engages in the manufacture, distribution, marketing, and retail of medicines and pharmaceutical products under the Pharmacy Direct, Curasana, Activo Health, and Scriptpharm brand names. In addition, it provides health insurance products for individuals and organisations; occupational health programmes; administration services for a market of medical schemes, …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
AfroCentric Investment Corporation reported revenue of R7.3B in FY2026 versus R8.7B in FY2022, a compound −4.3%/yr. Reported net income was −R1.3B in FY2026.
Is ACT fairly valued? → Check now
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$95.75 | R$123.65 | +29% |
| Fresenius SE FRE | €37.69 | €30.03 | -20% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $164.77 | $280.85 | +70% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.76 | R$30.33 | -7% |
| DaVita Inc DVAI34 | R$1,081 | R$207.69 | -81% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,305 | ₹2,546 | -69% |
| Fresenius Medical Care AG FMS | $23.59 | $34.71 | +47% |
| Aier Eye Hospital Group 300015 | ¥8.54 | ¥6.73 | -21% |
| Max Healthcare Institute Limited MAXHEALTH | ₹977.25 | ₹283.61 | -71% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is AfroCentric Investment Corporation (ACT) undervalued?
What is the fair value of ACT?
What is the quality score of ACT?
What is the revenue of AfroCentric Investment Corporation (ACT)?
What is the net profit margin of ACT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full AfroCentric Investment Corporation analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.